QB3—one of four California Institutes for Science and Innovation (CISI)—will celebrate the opening of its new headquarters at UCSF Mission Bay at a special event on November 28. Highlighting the program will be the announcement of major new industry-academic collaborations to advance clinical diagnosis and treatment.
General Electric, Genentech and Nikon will each announce a major initiative with QB3. Other research initiatives also will be reported for the first time.
MEDIA ARE INVITED TO COVER
2:30-5:30 PM, Monday, November 28
UCSF Mission Bay, Genentech Hall, 16th and Owens, in San Francisco
The theme is “Nurturing Biomedical Innovation.” Speakers are:
* Jeffrey Immelt, Chairman of the Board and CEO, General Electric—Announcing the new “GE/QB3 Partnership for Innovative Clinical Imaging”
* Arthur D. Levinson, Chairman and CEO, Genentech—“Innovation in the Biotechnology Industry”
* Robert Dynes, President, University of California—“The California Institutes for Science and Innovation: Catalysts for the Future” (discussing new UC-China collaborations)
* J. Michael Bishop, Chancellor, UCSF—“The Promise of QB3 for Discovery and Human Health”
* Brook Byers, Partner, Kleiner, Perkins, Caufield & Byers—Closing Remarks
* Regis Kelly, Executive Director, QB3—Master of Ceremonies
ABOUT QB3: QB3, the California Institute for Quantitative Biomedical Research, is the only one of the four CISI centers devoted to biomedical research. It brings together scientists from UC Berkeley, UC Santa Cruz and UCSF to apply intensely quantitative techniques to solve complex biological problems critical to advancing human health.
The institutes were conceived by the State of California to improve collaborations between university research scientists and those in the state’s technology industries in order to accelerate the translation of basic biomedical research discoveries into diagnostics, products and treatments to improve health and assure the growth of the state’s economy.
ABOUT UCSF: UCSF is a leading university that consistently defines health care worldwide by conducting advanced biomedical research, educating graduate students in the life sciences, and providing complex patient care.
FOR MORE INFORMATION: Contact Wallace Ravven in the UCSF News Office at (415) 476-2557.